Pharmaceuticals

The Medical Cannabis market in Australia is expected to achieve revenue of of US$195.20m by 2023

It is projected to experience a steady annual growth rate (CAGR 2023-2028) of 14.80%, leading to a market volume of US$389.20m by 2028.

When compared globally, in the United States is anticipated to generate the highest revenue of US$11,320m in 2023

In terms of per capita revenues, in Australia is estimated to generate US$7.38 in 2023

Australia’s medical cannabis market is rapidly growing with an increasing number of patients seeking alternative treatments for chronic conditions